In addition to this finding, Kaplan-Meier survival analysis demonstrated that patients with LUAD, LIHC, KIRP, and CHOL exhibited shorter OS when expressing high levels of LY6H; conversely, in patients with GBM, having higher LY6H expression was associated with better OS. This evidence concerns the gene LY6H and glioblastoma.